The document is a regulatory disclosure providing access to the audio recording of an Earnings Conference Call organized by Sai Life Sciences Limited.
The earnings call was held on 06th November 2026 (as referenced in the document body, though the header date matches the submission date).
The stated purpose of the event was to discuss the Unaudited Standalone and Consolidated Financial Results for the second quarter and half year ended 30th September 2026.
The meeting was scheduled post-declaration of the financial results, as explicitly stated in the document.
Management participants are not specified in this disclosure.
The company has made the audio recording of the earnings call available via a direct MP3 link and on its website investor section.
The recording is hosted at: https://sailife.com/wp-content/uploads/2026/11/Earnings-Call-Audio-Recording-Q2.mp3
The document does not contain any statement regarding unpublished price sensitive information (UPSI).
Additional Notes Section
The disclosure is made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The audio recording is also available on the company's website at: https://sailife.com/ → Investors → Financial Information → FY 2027 → Earnings Call Audio Recording → Q2 → Download
No financial data or figures are disclosed in this announcement; it solely provides access to the recording of the call where results were discussed.
The document is signed by Runa Karan, Company Secretary & Compliance Officer (Membership No. A13721).
